首次缓解期孤立性NPM1突变成人急性髓系白血病的造血干细胞移植
该回顾性研究比较了自体移植、同胞全合移植与全合无关供者移植在首次缓解期孤立性NPM1突变急性髓系白血病成人患者中的疗效。2年无白血病生存率同胞全合移植81%优于自体移植62%和无关供者移植69%,但2年总生存率三组无差异,均为83%。同胞全合移植与较低复发率和更好无白血病生存相关,年龄与较高非复发死亡相关。
要点
- 2年无白血病生存率:同胞全合移植81%,无关供者移植69%,自体移植62%(同胞全合 vs 其他 P=0.02)
- 2年总生存率三组无差异,均为83%(P=0.88)
- 2年累积复发率:自体移植30%,无关供者移植22%,同胞全合移植12%(P=0.01)
核心结论
- 同胞全合异基因移植似乎是年轻首次缓解期孤立性NPM1突变急性髓系白血病患者合理的移植选择。
- 自体移植后复发率和无白血病生存较差,但总生存与两种异基因移植方式相似。
研究设计与样本
- 回顾性比较自体移植、同胞全合移植与全合无关供者移植的移植策略研究。
- 纳入256例成人患者,其中自体移植125例,同胞全合移植72例,无关供者移植59例。
主要发现
- 2年无白血病生存率:自体移植62%,无关供者移植69%,同胞全合移植81%(同胞全合 vs 其他 P=0.02)。
- 2年总生存率三组无差异,均为83%(P=0.88)。
- 2年非复发死亡率:自体移植2.5%,异基因移植7.5%(P=0.04)。
- 2年累积复发率:自体移植30%,无关供者移植22%,同胞全合移植12%(P=0.01)。
- 多因素分析中,同胞全合移植 vs 自体移植与较低复发率(P<0.01)和更好无白血病生存(P=0.01)相关;无关供者移植 vs 自体移植未达统计学显著(复发率 P=0.13,无白血病生存 P=0.31)。
临床怎么用
- 原文结论认为同胞全合异基因移植似乎是年轻首次缓解期孤立性NPM1突变急性髓系白血病患者合理的移植选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) in first remission (CR1) with isolated NPM1 mutation (iNPM1m) is considered a good prognosis genotype, although up to one-third relapse. To evaluate the best transplant strategy, we retrospectively compared autologous stem cell transplantation (auto-SCT), related (MSD), and fully matched unrelated (MUD) allogeneic stem cell transplantation (allo-SCT). We identified 256 adult patients including 125 auto-SCT, 72 MSD, and 59 MUD. The 2-year leukemia-free survival (LFS) was 62% in auto-SCT, 69% in MUD, and 81% in MSD (P = .02 for MSD vs others). The 2-year overall survival (OS) was not different among auto-SCT, MUD, and MSD, reaching 83% (P = .88). The 2-year non-relapse mortality (NRM) was 2.5% in auto-SCT and 7.5% in allo-SCT (P = .04). The 2-year cumulative incidence of relapse (RI) was higher after auto-SCT (30%) than after MUD (22%) and MSD (12%, P = .01). In multivariate analysis, MSD versus auto-SCT but not MUD versus auto-SCT was associated with lower RI (P < .01 and P = .13, respectively) and better LFS (P = .01 and P = .31, respectively). Age correlated with higher NRM (P < .01). Allo-SCT using MSD appears as a reasonable transplant option for young patients with iNPM1m AML in CR1. Auto-SCT was followed by worse RI and LFS, but similar OS to both allo-SCT modalities.
引用
- Poiré X, Labopin M, Polge E, et al. Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. Am J Hematol. 2018. PMID: 30456896. doi:10.1002/ajh.25355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。